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ABSTRACT  
 
Genetic evidence has implicated several genes as being critical for heart development. 
However, the inducers of these genes as well as their targets and pathways they are 
involved with, remain largely unknown. Previous studies in the avian embryo showed 
that at HH4 Cerberus (cCer) transcripts are detected in the anterior endomesoderm 
including the heart precursor cells and later in the left lateral plate mesoderm.  
We have identified a promoter element of chick cCer able to drive EGFP expression in 
a population of cells that consistently exit from the anterior primitive streak region, 
from as early as stage HH3+, and that later will populate the heart. Using this promoter 
element as a tool allowed us to identify novel genes previously not known to potentially 
play a role in heart development. 
In order to identify and study genes expressed and involved in the correct development 
and differentiation of the vertebrate Heart Precursor Cell (HPC) lineages, a differential 
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screening using Affymetrix GeneChip system technologies was performed. 
Remarkably, this screening led to the identification of more than 700 transcripts 
differentially expressed in the Heart Forming Regions (HFR). Bioinformatic tools 
allowed us to filter the large amount of data generated from this approach and to select a 
few transcripts for in vivo validation. 
Whole-mount in situ hybridization and sectioning of selected genes showed heart and 
vascular expression patterns for these transcripts during early chick development.  
We have developed an effective strategy to specifically identify genes that are 
differentially expressed in the HPC lineages. Within this set we have identified several 
genes that are expressed in the heart, blood and vascular lineages, which are likely to 
play a role in their development. These genes are potential candidates for future 
functional studies on early embryonic patterning. 
 
1. Introduction  
 
The genetic control of the heart development is a very complex and still poorly 
understood process. During early development, the heart of chick and humans has 
similar morphologies (De la Cruz et al., 1989) and most cardiovascular malformations 
found in the avian embryo are analogous to those found in humans (Nishibatake et al., 
1987). 
In the chick embryo, at developmental stage HH3, cardiac progenitor cells have been 
mapped to the anterior two thirds of the primitive streak (PS), excluding Hensen’s node 
(HN; Garcia-Martinez and Schoenwolf, 1993). After ingression, these cells migrate 
anteriorly and laterally in a semicircular trajectory with slight or no mixture of cells and 
at stages HH4-5 cardiac progenitors are located on either side of HN in the anterior 
mesoderm (Yang et al., 2002; Yue et al., 2008; Cui et al., 2009). At stage HH6, when 
the lateral plate mesoderm dissociates into the splanchnic and somatic mesoderm layers, 
myocardial and endocardial progenitors are constrained to the splanchnic mesoderm and 
constitute the heart fields. These bilateral heart fields fold ventrally and, in the midline, 
give rise to the linear heart tube between HH9 and HH11 (Stalsberg and DeHaan, 1969; 
Linask, 1992; DeRuiter et al., 1992; Abu-Issa and Kirby, 2007). By this stage the heart 
tube undergoes progressive rightward looping, giving rise to a four chambered heart (De 
la Cruz et al., 1989). 
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Studies to identify the heart forming regions (HFR) in the avian embryo have been 
carried out since the early 1900s, and over the years several fate map studies have been 
undertaken. These fate map studies have established accurate boundaries for the HFR 
during early development (Redkar et al., 2001; Hochgreb et al., 2003). Among these 
studies there is a dynamic positional fate map, undertaken by Cui and colleagues that 
allowed to trace precardiac cells from the moment they exit the PS until the formation 
of the tubular heart (HH3+ to HH10; Cui et al., 2009). Early heart formation studies 
have proven this process to be a very complex one. Genes such as BMP-2 and Nkx2.5, 
although having a functional role in cardiac development (Ehrman and Yutzey, 1999), 
were found not to be able to demarcate the entire primary heart-forming region during 
early developmental stages (Jiang et al., 1998; Kostetskii et al., 1999; Redkar et al., 
2001; Eisenberg, 2002; Hochgreb et al., 2003; Cui et al., 2009). Moreover, several 
distinct cell populations were proven to contribute to the formation of  the adult heart 
(Martinsen, 2005) including a primary and a secondary heart field, identified by the 
expression of specific markers (Kelly et al., 2001; Waldo et al., 2001; Mjaatvedt et al., 
2001). 
Cerberus-like genes encode for cysteine-knot secreted proteins that behave as 
antagonists of members of the transforming growth factor-β (TGF-β) family during 
development (Hsu et al., 1998; Piccolo et al., 1999; Rodriguez-Esteban et al., 1999; 
Belo et al., 2000; Belo et al., 2009). The Xenopus Cerberus (Xcer) gene was first 
identified as a Spemann organizer associated transcript that encodes a secreted protein 
capable of inducing ectopic heads and duplicated hearts and livers, when injected into 
Xenopus eggs (Bouwmeester, 1996). Also, both Cerberus and its mouse homologue 
Cer1 induce upregulation of Nkx2.5 (Bouwmeester et al., 1996; Belo et al., 1997), and it 
has been demonstrated that the XCer expressing endoderm is required for heart inducing 
activity (Schultheiss et al., 1995; Schneider and Mercola, 1999; Marvin et al., 2001). 
Xenopus Cer, mouse cer1 and cCer transcripts are detected in equivalent embryonic 
structures, the anterior endomesoderm, anterior visceral endoderm, and hypoblast, 
respectively (Bouwmeester et al., 1996; Belo et al., 1997; Rodriguez-Esteban et al., 
1999; Liguori et al., 2008). Additionally, in chick and mouse embryos, the expression of 
these genes is also present in the anterior definitive mesendoderm (Rodriguez-Esteban 
et al., 1999; Belo et al., 1997). 
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In previous work aiming to study the transcriptional regulation of cCer, we set up a 
reporter assay for heart/hemangioblast cell populations in the chick embryo. The study 
uncovered a 2.5 kb fragment upstream of the ATG of chick Cer that was able to drive 
the expression of EGFP into cell populations that express cCer such as the anterior 
mesendoderm, lateral plate mesoderm, heart and anterior blood islands or 
hemangioblasts (Tavares et al., 2007; data not shown). Aiming to identify 
uncharacterized genes that may play a role in heart development we used the 2.5Cer 
EGFP reporter to isolate an early cardiac endomesodermal population. This cell 
population was selected as representative of the HFR in a differential screening that 
resulted in more than 700 differentially expressed transcripts. The outcome of the 
screening is a genetic profile of the HFR at stage HH4, which provides a hint for 
cardiogenic precursor lineage identity. Moreover, we describe the expression patterns 
for four previously uncharacterized genes, and show that CHEP18, CHEP33, CHEP40 
and cAdtk1 are differentially expressed in the cardiogenic region in early chick 
embryos.  
 
2. Results 
 
2.1. Cer2.5-EGFP reporter construct is expressed in early heart precursor cells 
(HPC) 
  
In previous work, we have reported that the cCer2.5-EGFP construct, a 2.5 kb DNA 
fragment upstream of the ATG of cCer subcloned into an EGFP reporter vector, was 
functional and able to drive EGFP expression into the anterior mesendoderm and lateral 
plate mesoderm (Tavares et al., 2007). In order to further characterize cCer2.5-EGFP 
expression, embryos at HH3 were electroporated with the cCer2.5-EGFP reporter 
construct and cultured (New, 1955). The pCCAGS-AFP promoter was used as control.  
 
EGFP fluorescence could be observed in the anterior mesendoderm at early stages HH4-
6 (Fig. 1A, A’, B and C), in the prospective extraembryonic mesoderm and heart 
precursor cells at HH7 (Fig. 1D, D’), in the extraembyonic mesoderm and precardiac 
region at HH9 (Fig. 1F, F’), and, later on, populating the heart and the anterior blood 
islands (Fig 1G, G’, G’’). This EGFP expression is consistent with chick Cerberus 
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expression at early stage HH4, as visualized by whole-mount in situ hybridization (Fig. 
1H). The specificity of these results was confirmed upon comparison with the 
ubiquitous fluorescence observed in the pCCAGs-AFP electroporated control embryo 
(Figure 1E). 
 
2.2. Isolation of heart precursor cells (HPC) and RNA collection 
 
To identify transcripts differentially expressed during early cardiac development in the 
cCer2.5-EGFP positive population, we microdissected this region at stage HH4, and 
dissociated the tissue into a single cell suspension. The EGFP positive cells from the 
HFR pool were sorted using FACS. The negative control population was derived from 
the posterior part of the primitive streak (PPPS), a non cardiac region, to minimize the 
risk of losing unknown cardiac genes that are expressed in the mesendoderm tissues. 
The subtractive hybridization scheme is outlined in Figure 2A. 
 
Prior to sorting, we evaluated whether the cells from the targeted areas were typical 
embryonic chick cells (Fig. 2B). Indeed, the R3 region contains cells with a level of 
granularity similar to that seen in the control embryonic chick cells (data not shown). 
This approach yielded successful separation of the two different populations (EGFP 
negative versus EGFP positive cells; Fig. 2C). In the R8 gated region, approximately 
6% of the total number of cells was EGFP-positive. To assess purity and viability of the 
HPC a preliminary sorting process of approximately 100 cells was conducted. This 
initial FACS analysis of the sorted EGFP-labeled cells indicated a cell viability and 
purity of 99% (data not shown), confirming that no EGFP negative cells had been 
collected and that the mechanical stress exerted on the cells during FACS had no effect 
on their viability. The complete cell suspension was then sorted resulting in the isolation 
of approximately 4000 EGFP positive cells. These cells were collected directly for RNA 
extraction. Despite the low number of cells a high quality RNA sample was obtained. 
Due to the limiting amount of total RNA extracted from the isolated cells, a two round 
linear amplification method was employed to obtain the required amount of fragmented 
biotinylated cRNA for hybridization to the GeneChip microarray.  
The cRNA pool obtained from the first cycle of amplification was analyzed for the 
relative presence/absence of known markers in order to test the feasibility of the 
	   6	  
differential screening (Fig. 2D). We used cCer as a marker of early endomesoderm, 
cNodal as a PS marker and cNot1 as a HN marker. The EGFP positive population only 
expressed cCer. The PPPS population was positive for cNodal and cCer. cNot1 
expression was absent in both EGFP positive and PPPS populations. The whole embryo 
was positive for all the markers. All cell populations expressed GAPDH that was used 
as a reference gene. 
 
2.3. Identification and functional network analysis of differentially expressed genes 
in heart precursor cells 
 
The Affimetrix GeneChip® Chicken Genome array was used to compare the cRNA 
pools of EGFP positive and PPPS cell populations. The resultant data were classified 
and organized, using DAVID and IPA tools. 
 
The differential screening resulted in the detection of 777 genes that are differentially 
expressed with a fold change greater than 2. The microarray data used in this analysis 
has been submitted to NCBI GEO database under accession number GSE23389 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23389).  
Gene ontology analysis was carried out on significantly regulated transcripts using 
DAVID (http://david.abcc.ncifcrf.gov/). The transcripts were organized (Figure 3A) 
into an upregulated population that contains a total of 437genes, which includes 301 
uncharacterized (119 unknown genes and 182 annotated genes), and 136 characterized 
(of which 38 have GeneRIF). This gene expression screening also revealed 340 
downregulated genes in the HPC enriched cell population, of these 205 were 
uncharacterized (80 unknown genes and 125 annotated genes), and 135 characterized 
(of which 44 have GeneRIF).  
The detailed analysis of the obtained list of characterized upregulated genes in the 
EGFP positive population showed that several were previously associated with HPC 
populations, such as Fgf8, TNNT2, NRP1, Isl-1 and Wnt11 (Fig. 3B).  
We used Ingenuity Pathway Analysis (Ingenuity® Systems, www.ingenuity.com) 
algorithms and database to dynamically generate significant biological networks from 
the gene expression data sets.  From the analysis of the pool of upregulated 
characterized genes resulted a list of associated network functions, being Cellular 
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Movement, Cardiovascular System Development and Function, Cellular Development 
the network with highest score (45; Table1).  
 
2.4. Validation of the differentially expressed candidate genes in the heart precursor 
cells 
 
From the list of upregulated uncharacterized genes, we selected a number of genes for 
expression pattern characterization. The selection was based on their fold change and 
predicted function. 
We named them CHEP33 (which stands for Chick Heart Progenitor #33), CHEP36, 
CHEP40 and CHEP18. CHEP36 was also found in a previously screening for Anterior 
Visceral Endoderm genes performed in our lab, and denominated as ADTK1 (Anterior 
Distal Tyrosine Kinase 1; Gonçalves et al, 2011). For that reason this gene will be 
renamed as cAdtk1 in this manuscript. 
 
The cAdtk1 gene (GenBank accession no. CR405754.1) is 6,8 fold upregulated in the 
HFR when compared with the posterior part of the Primitive streak. Whole-mount in 
situ hybridization of cAdtk1 (Fig. 4A-H) showed that it is expressed as early as stage 
HH4 in the anterior mesendoderm (Fig. 4A) with an expression pattern similar to that of 
cCer (Fig. 1H). At stage HH5-6 expression is restricted to a mesodermal area on either 
side of the embryo overlapping the heart fields and in a more medial ectodermal region 
on both sides of the head process (Fig. 4B, C and C’). At stage HH7-8 expression is 
seen in both in the lateral plate mesoderm and in the proamnion (extra-embryonic 
ectoderm and extra-embryonic endoderm) (Fig. 4D, D’, D’’ and E). By stage HH9, 
cAdtk1 seems to be expressed in the wall of sinus venosus (Fig. 4F and F’). At stage 
HH10, expression appears to be restricted to the heart tube region and and lateral plate 
mesoderm (Fig. 4G). At later stages by HH14 expression persists in the lateral plate 
mesoderm and amnion, and a new expression domain can be seen in the tail bud 
mesoderm (Fig. 4H and data not shown). 
 
CHEP33 (GenBank accession no. XM_421599) was obtained in the differential 
screening with a +4,4 fold change, and encodes for a putative protein of 239 amino 
acids. The predicted amino acid sequence of chick CHEP33 is identical 90,8% and 
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90,5% to its human and mouse orthologs respectively and contains a predicted Zinc-
finger motif. Expression of CHEP33 was initially detected at stage HH4 by whole-
mount in situ hybridization in bilateral prospective heart fields on the left and right sides 
of the embryo (Fig. 4I). At stage HH5 CHEP33 transcripts are detected in a large 
mesodermal area (Fig. 4J, J’) and by stage HH7-8 expression can be observed in the 
lateral plate mesoderm where heart precursors lay, and in the forming somites (Fig. 4K). 
By stage HH9, expression is visible in the forming heart tube and in the somites (Fig. 
4L). At stage HH11-12, the heart is intensely labeled, as well as the somites and 
staining in the head and lateral plate mesoderm becomes evident (Fig. 4M-N). 
Histological sections shown that CHEP33 is present specifically in the myocardium, 
pharyngeal endoderm, neural tube, derma-myotome and somatic lateral plate mesoderm. 
Later in development CHEP33 is strongly expressed in the heart (Fig. 4O). 
 
CHEP40 gene (GenBank accession no. XM_418631.2) was detected in the screening 
with a +5,0 fold change, and encodes for a putative protein of 893 a.a. The predicted 
amino acid sequence of chick CHEP40 has several homologues in other species, and 
contains a putative transmembrane domain in the medial portion of the protein. It also 
contains conserved domains predicted to be involved in cell adhesion, like the 
desintegrin and Protocadherin domains. Whole-mount in situ hybridization showed that 
by stage HH4+ CHEP40 transcripts are detected in the HFR mesoderm (Fig. 5A, A’ and 
A’’). However, they are also present in the three germ layers of the area pellucida of the 
embryo, but absent in the primitive streak. At this stage of development, transcripts of 
CHEP40 are also detected in the	  posterior part of the area opaca. At stage HH6, 
CHEP40 is highly expressed in the area pellucida except for the head process, 
Hensen’s node and primitive streak. Some staining is also observed on the 
extraembryonic part of the embryo (Fig. 5B). Later in development, at HH8 CHEP40 
transcripts are present in the heart primordium (Fig. 5C) and at stages HH10 to 14 
CHEP40 transcripts were detected in the heart endocardium, intraembryonic 
vasculature, anterior intestinal portal and neural fold tip (Fig. 5D-F and D’-E’’).  
 
CHEP18 (GenBank accession no. XM_416761) was found to be upregulated with a 
+6,8 fold change, and encodes for a hypothetical protein of 388 a.a. with potential 
orthologs in several organisms. CHEP18 belongs to the VHS ENTH-ANTH 
superfamily, more specifically to VHS_Tom1, VHS domain family, Tom1 subfamily. 
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Whole-mount in situ hybridization showed that at stage HH4 (Fig. 5G) the expression 
of CHEP18 is limited to the extraembryonic mesoderm of the posterior part of the 
embryo, whilst at stage HH5 (Fig. 5H and H’) is possible to observe staining on either 
side of the embryo in the mesodermal cells that border the area pellucida known to 
belong to the HFR, as well as in two mesodermal patches of labeled cells on both sides 
of the Hensen’s node (black arrowheads). From stage HH6 to 8 (Fig. 5I-K and J’-K’’) 
the expression remains in the extraembryonic mesoderm as well as on both sides of the 
Hensen’s node, however, the intraembryonic mesodermal expression appears to 
progress medially. Later in development, at HH10 (Fig. 5L, L’ and L’’) CHEP18 
transcripts are present in the extraembryonic vasculature as well as in the 
intraembryonic vasculature and in the heart, more specifically in the endocardium. 
Finally at stage HH15, the expression of CHEP18 persists in the heart as well as in the 
vasculature including the posterior cardinal veins and head microvessels (Fig. 5M and 
M’). 
 
3. Discussion  
 
The heart is the first organ to become functional in the vertebrate embryo. It develops 
from two bilateral heart fields located in the anterior lateral mesoderm of the early 
embryo, which are formed during gastrulation. A vast array of genes and signaling 
pathways have been reported to be crucial in all steps of cardiogenesis, from migration 
of primitive-streak progenitor cells, formation of primary and secondary heart fields, 
fusion of cardiac crescent cells, cardiac looping, to later morphogenetic mechanisms. 
Developmental signaling pathways are required to act in combination with tissue-
specific transcriptional cofactors to elicit inductive responses. The spatial and temporal 
orchestration of these processes implies a complex program of genetic control, exerted 
in large part through precisely controlled processes of cell-cell signaling and regulators 
of gene expression. 
We generated a cCer2.5-EGFP construct that effectively produces specific expression in 
cells leaving the PS at HH3+ and later populate the heart tube. 
To confirm the identity of the isolated cell population, a RT-PCR analysis was 
performed. Known cardiac genes such as NKX2.5 and GATA4 were not used in this 
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analysis because they are only expressed later, by stage HH5 (Abu-Issa and Kirby, 
2007; Warkman et al., 2008). For that reason we used cCer as a marker of early 
endomesoderm, cNodal as a PS marker, and cNot1 as an HN marker. Our results were 
in agreement with the expected since the selected EGFP+ cell population expresses 
cCer and doesn’t express cNodal, suggesting that we have isolated an enriched 
population of endomesoderm containing heart precursor cells. The presence of cCer 
transcripts in the PPPS region can be explained since at stage HH4 cCer expressing 
cells are leaving the primitive streak toward the cardiogenic mesoderm,	  and the 
dissected posterior region contains some of these cells (Fig. 1H). 
A successful combination of methods was employed, resulting in the isolation of 777 
independent transcripts potentially implicated in early heart development at stage HH4. 
These results were catalogued using DAVID (Figure 3A). In our study, reference genes 
as Actin and GAPDH showed no fold change, since they are ubiquitously expressed in 
all eukaryotic cells (Fig. 3B). This also indicates that the EGFP positive population and 
the negative control have a similar number of cells. We defined as upregulated genes, 
those found differentially expressed and increased in the EGFP-positive population 
when compared with the control population. From the pool of upregulated genes, 
several known cardiac genes were found to be present, some of which with great 
relevance during early heart development. Both NRP1 and Wnt11 genes were strongly 
expressed in the EGFP-positive cell population and have been previously implicated in 
HPC mechanisms. NRP1 has been described to be a pro-angiogenic receptor (Ball et al., 
2010), and that in order to promote cardiomyogenesis, the Wnt canonical pathway must 
be blocked by Wnt inhibitors, such as Wnt11 (Marvin et al., 2001; Maye et al., 2004). 
Multipotent cardiovascular progenitor cells, which express Isl1 together with Nkx2.5 
and Flk-1, give rise to cardiomyocytes, smooth muscle cells, and endothelial cells, 
representing all three major cell lineages of the heart (Moretti et al., 2006). Flk-1 and 
Isl1 expressions were found to be upregulated in the EGFP positive population. Another 
gene found to be enriched in this cell population was TNNT2, which is known to be 
present in the embryonic heart of the chick and is responsible for binding tropomyosin 
to regulate calcium binding and contractility of heart muscle (Druyan et al., 2007). Fgf8 
is one of the earliest genes known to regulate myocardial progenitor cells, that when 
reduced in expression leads to abnormal heart development. Though WISH studies at 
HH4 show its expression occurs in the cranial part of the PS (Dathe et al., 2002), we 
also found it to be enriched in the HPC when compared to our control cell population. 
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Therefore, the interpretation of some results might not be immediate, as several 
differentially expressed genes are known to be involved in vasculogenic and angiogenic 
processes (Flk1, VEGF-D and VE-cadherin). Additionally, multiple genes associated 
with hemangioblast fate, including Flk-1 and Scl were detected. This led us to suppose 
that along with the cardiac precursor cells, hemangioblasts were also isolated. The 
hemangioblast was proposed a long time ago to be the common precursor for 
endothelial and hematopoietic cells, and the hemangioblast cells of the lateral plate 
mesoderm can give rise to both the angioblasts of the vascular system and the 
pluripotential hematopoietic stem cells of the blood and lymphoid systems. The 
primitive endothelial and hematopoietic lineages are believed to derive from 
mesodermal cells that have migrated from the PS to form the blood islands in the 
extraembryonic yolk sac, being Flk-1 and Scl two critical molecules involved in this 
process (Murray, 1932; Ema et al., 2003). It has also been reported that the region in the 
mesoderm posteriorly adjacent to the cardiogenic region is responsible for the 
emergence of the blood precursors. We assume that the presence of both heart and 
hemangioblast precursor cells in our differential screening can be explained by the use 
of 2.5cCer as a reporter. This transgene also drives the expression of EGFP in the 
anteriormost hemangioblast population (Fig. 1F and G), which is contiguous to the 
cardiac precursor cells region. However the isolation of both cell precursors doesn’t 
invalidate our aim to study cardiogenesis. In a study performed in zebrafish, a close 
genetic link between anterior hemangioblast and cardiac precursors was identified 
which supports the notion that the anterior hemangioblast population is an evolutionary 
ancestor of the second heart field (Peterkin et al., 2009). Moreover, cardiomyocytes 
have been obtained from ES cell derivatives expressing the hemangioblast marker, 
VEGF receptor, Flk-1, which is consistent with the idea of common genetic programme 
(Kattman et al., 2006). It is known that the cardiogenic process at such early stages 
needs BMP signaling from the anterior endoderm (Schultheiss et al., 1997), to induce a 
field with cardiogenic competence, and it is also known that in this region Wnt 
inhibition is necessary to promote cardiomyogenesis (Schneider and Mercola, 2001; 
Marvin et al., 2001). As we mentioned before, Wnt11, an inhibitor of the Wnt canonical 
pathway (Maye et al., 2004), was found to be more expressed in sorted cells, which was 
to be expected since it should be present to promote cardiomyogenesis. However, Bmp2 
and Bmp4 were not found to be enriched in the HPC. This is probably due to the fact 
	   12	  
that the region selected as negative control also expresses these genes at a similar 
expression level (Marvin et al., 2001; Brand, 2003). 
IPA tool was used to evaluate if the characterized genes found enriched in the EGFP 
positive population, were together due to random change. A list of associated network 
functions was produced being Cellular Movement, Cardiovascular System Development 
and Function, Cellular Development the one with highest score (45; Table1), meaning 
that there is a 1 in 2250 chance that the Focus Genes are together due to random chance. 
The enrichment of cardiac specific genes in the EGFP population, together with the 
functional in silico characterization of the differentially regulated transcripts, 
strengthens the possibility that heart precursor cell isolation was accomplished.  
Following categorization of the genes differentially expressed in the HPC at stage HH4, 
we focused our study on the 301 upregulated uncharacterized transcripts. Aware of the 
possible existence of false positives among these novel genes due to the absence of 
replicates for our arrays, we performed whole-mount in situ hybridizations to determine 
if they fitted HPC expression. Four genes were chosen for further characterization: 
CHEP33 a novel gene with a putative zinc finger binding domain; cAdtk1 containing a 
predicted dual-specificity Ser/Thr/Tyr kinase catalytic domain; CHEP40 a novel gene 
possibly involved in cell adhesion and CHEP18 that belongs to the VHS ENTH-ANTH 
superfamily. The whole-mount in situ hybridizations performed in this study showed 
that the expression patterns of the novel genes overlap with the HPC region. However, 
expression of CHEP18 at stage HH4 is absent in the HFR. This could be due to a weak 
expression level that would not be detected by whole-mount in situ hybridization. Or, as 
there is a narrow window of time between stages HH4 and HH5, it is possible that some 
embryos collected for the screening could have been at an early HH5 stage, and already 
expressing CHEP18 in the HFR. As for the expression of CHEP40 at stage HH4, 
expression can be observed almost all over the area pellucida, being however weaker in 
the posterior part of the embryo than in the HFR. At first this fact seems to invalidate 
the experimental approach used as the basis of this study, however by analyzing the 
expression pattern carefully, it can be seen that both the posterior part of the embryo and 
the primitive streak are less stained than the HFR. As this screening is a differential one, 
one cell population versus another, the plausible explanation of these results is that 
CHEP40 is expressed 5 times more in the HFR mesoderm than in the posterior part of 
the primitive streak. The posterior part of the area opaca at HH4 is usually associated to 
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vascular cell populations, which can explain CHEP40 expression at HH10 in the 
intraembryonic vessels. At early cardiac formation stages expression was found in the 
heart for CHEP33, CHEP18 and CHEP40. cAdtk1 is present in HFR during pre-heart 
tube stages, being as well present in structures adjacent to the heart after its formation. 
This gene, as previously described in mouse embryos, is also absent from the heart tube 
at early cardiac stages (Imuta et al., 2009). Nevertheless it has been described to be 
strongly expressed in the heart of adult mice. In the mouse, at E6.5 Pkdcc (cAdtk1 
ortholog) is expressed in the anterior viseral endoderm and anterior PS, whereas in the 
chick at HH4 there is no expression in the PS. In the chick at HH5 cAdtk1 is expressed 
in the HFR mesoderm and in the neural plate ectoderm, whereas no ectodermal 
expression is seen in the mouse at E7.5. WISH studies of the four selected clones 
allowed us to corroborate the hypothesis that the cCer positive population expresses 
cardiogenic genes. This was proven by the detection in the heart, later in development, 
of transcripts of these studied genes. Furthermore, the expression of the new clones in 
the mesendoderm at stage HH4, validates the differential screening which involved the 
RNA isolated from these cells at the same stage.  
 
In conclusion, we have identified a large set of novel genes that are differentially 
expressed in the H/HPC precursor lineages. By developing a procedure to isolate the 
heart precursor cells using the cer2.5-EGFP construct, we were able to specifically 
separate a population of H/HPC expressing already known cardiac markers, and a long 
list of still uncharacterized genes. From those, we demonstrated by WISH that a number 
of these in silico-identified transcripts are in fact expressed in these cell populations and 
potentially required for heart formation. More importantly, our study unveiled a large 
number of uncharacterized genes that can now be used by the scientific community for 
further developmental studies. 
 
4. Methods 
 
4.1. DNA constructs and morpholinos 
The pCAGGS-AFP vector (Momose et al, 1999), carrying the cDNA of the green 
fluorescence protein under the control of the CAGGS promoter, was used to control the 
extent and efficiency of electroporation. 
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The pCer2.5-EGFP vector contains a 2.5Kb fragment upstream the ATG from the 
Cerberus regulatory region. 
4.2. Chick embryo isolation, culture and electroporation method 
Fertilized chicken eggs (Sociedade Agrícola Quinta da Freiria, SA, Torres Vedras, 
Portugal) were incubated until the desired stage was reached according to Hamburger 
and Hamilton (1951) at 37,5°C. Embryos were explanted at HH stage 3+ together with 
the vitelline membrane and anchored to a metacrilate ring following the protocol of 
New (1955).  
Embryos were microinjected and electroporated as described previously (Tavares et al., 
2007) at HH stage 3 with a DNA solution (0.5-3 mg/ml; 0.1% Fast Green; Sigma). The 
embryos were incubated at 37 °C for the appropriate period of time (7-48h), and 
observed under a fluorescence stereomicroscope (Leica MZ16FA) and further dissected. 
4.3. Excision of the GFP expressing HFRs and FACS analysis 
The HFR reside in bilateral regions on either side of Hensen’s node of a stage HH3+-4 
embryo. The chick embryos (n=6, n refers to the number of embryos successfully 
electroporated) were collected at stage HH4 and two different pools were made: one 
comprising the region containing the EGFP-Positive cells, and another the posterior part 
of the primitive streak (PPPS). Both regions were removed and washed in cold PBS. 
The PPPS proceeded directly for RNA extraction. 
The tissues containing the EGFP positive cells were subjected to 5 minutes digestion in 
0.25% trypsin/PBS at RT and triturated 10–20 times with a 1000 µL pipette. PBS 
containing 10% FBS (Hyclone) was added followed by centrifugation. Cells were 
ressuspended in PBS/2%FBS, filtered through a sterile stainless nylon mesh and 
proceeded for FACS analysis.  
Fluorescence-activated cell sorting was performed in a Moflo High-Speed Cell Sorter 
(Dako-Cytomation), using a 100-µm ceramic nozzle with 30 psi sheath pressure, a 488-
nm laser line from a Coherent Sapphire 488 to 200 CDRH laser for GFP excitation. 
GFP was detected using a 530-/40-nm band pass filter. 
An initial gate (R3, Fig.2A) is set on a FSC (Forward scatter) vs. SSC (Side scatter) dot 
plot to contain the cell population based on their cell size and intracellular complexity, 
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similar to that seen in the control embryonic chick cells performed before (data not 
shown). 
The events in gate R3 are then displayed on a second dot plot (Fig. 2C) and a second 
gate is set to contain the GFP positive population. FL1 vs. FL2 are the intensity of light 
detected in green (FL1, GFP) and yellow light channels (FL2). Compensation was 
applied.  
Cells in the gated region R8 were sorted with a sorting rate of ∼1 cell per second and 
100 cells were initially collected and then tested. FACS analysis (Becton Dickinson 
FacsCalibur cytometer) of these post-sorting GFP-labeled cells indicated a cell viability 
and purity of 99% (data not shown). The GFP positive cells were sorted directly to an 
Eppendorf tube containing 1ml of TRizol Reagent (Invitrogen). 
 
4.4. RNA isolation, target synthesis and hybridization to Affymetrix GeneChips 
Total RNA was extracted from cells by using TRIzol Reagent (Invitrogen) according to 
the manufacturer's instructions with the following modification; cells were lysed using 
1mL of TRIzol. The cell lysate was ressuspended with a pipette several times, vortexed 
for 30s and incubated at room temperature for 5min. Five µg of linear acrylamide 
(Ambion, Inc.) were added to the samples and transferred to a Phase Lock Gel (PLG) 
Heavy 2ml tube (Eppendorf AG); 0.2vol. of chloroform:isoamyl acid (25:1) was added 
to the sample, and mixed vigorously for 15 s. Samples were incubated for 2-3 minutes 
at RT and centrifuged at 12000 ×g for 15min. at 4ºC. The upper aqueous phase was 
transferred to a new PLG Heavy tube and a second extraction with 0.2 vol. 
chloroform:isoamyl acid (25:1) was performed. The aqueous phase was transferred to a 
nuclease-free tube and the total RNA was precipitated O/N at -20ºC with 0.8 vol. of 2-
propanol. Total RNA was collected by centrifugation at 14000 ×g for 40 min. at 4ºC, 
and the pellet was washed twice with 1ml of 80% ethanol at -20ºC. The pellet was air 
dried and ressuspended in 6µl of nuclease-free water (Promega Corp.), of which 1µl 
was used to determine RNA concentration and purity in a NanoDrop® ND-1000 UV-
Vis Spectrophotometer (NanoDrop Technologies), being integrity confirmed using an 
Agilent 2100 Bioanalyzer with a RNA 6000 Nano/ pico Assay (Agilent Technologies, 
Palo Alto, CA).  
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RNA was processed for use on Affymetrix (Santa Clara, CA, USA) GeneChip Chicken 
Genome Arrays, according to the manufacturer’s Two-Cycle Target Labeling Assay. 
Briefly, 45 ng of total RNA containing spiked in Poly-A RNA controls (GeneChip 
Expression GeneChip Eukaryotic Poly-A RNA Control Kit; Affymetrix) was used in a 
reverse transcription reaction (Two-Cycle DNA synthesis kit; Affymetrix) to generate 
first-strand cDNA. After second-strand synthesis, double-stranded cDNA was used in 
an in vitro transcription (IVT) reaction to generate cRNA (MEGAscript T7 kit; Ambion, 
Austin, TX). The cRNA obtained was used for a second round of cDNA and cRNA 
synthesis, resulting in biotinylated cRNA (GeneChip Expression 3’-Amplification 
Reagents for IVT-Labeling; Affymetrix). Size distribution of the cRNA and fragmented 
cRNA, respectively, was assessed using an Agilent 2100 Bioanalyzer with a RNA 6000 
Nano Assay. 
15 µg of fragmented cRNA was used in a 300 µl hybridization containing added 
hybridization controls. 200 µl of mixture was hybridized on arrays for 16 h at 45°C. 
Standard post hybridization wash and double-stain protocols (EukGE-WS2v5) were 
used on an Affymetrix GeneChip Fluidics Station 400. Arrays were scanned on an 
Affymetrix GeneChip scanner 3000. All quality parameters for the arrays were 
confirmed to be in the recommended range. 
4.5. Semi-quantitative RT-PCR 
After the first cycle of amplification described above, a semi-quantitative RT-PCR 
method using primers for known markers was performed to check the representativity 
of the cRNA pools. The cDNA was prepared according to the RevertAid™ H Minus 
First Strand cDNA Synthesis Kit protocol (Fermentas) as suggested by the 
manufacturer. Semi-quantitative RT-PCR was performed (BioRad). Gene expression 
levels were measured by the ΔΔ Ct method, comparing the EGFP positive population, 
the PPPS population and whole embryos controls, with GAPDH used as the reference 
gene. Pre-microarray validation was performed from the same samples used for the 
microarray experiment. The Semi-Quantitative RT-PCR primers were the follow; 
GAPDH: FW - 5’ ATG CAT CGT GCA CCA CCA AC  3’, Rev - 5’ CTC CAG ACG 
GCA GGT CAG GT 3’ ; cNot: FW - 5’ GCA GCA GTA CAT GGT GGG CAC AGA 
GC 3’, Rev - 5’ GCA TCC CCA GTA CCT CCA TCA GGC 3’; cNodal : FW - 5’ GCA 
CCG CCG CAC CAG GAA GGA GAG 3’, Rev - 5’ GCA CGG CAC CTG GCT GGG 
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CTT GTA 3’, cCer: FW - 5’ GAT  CTG AGA ACC TGG GCA GC 3’, Rev - 5’ CAC 
TGG GAC AGA ACT GGT GC 3’. 
4.6. GeneChip data analysis 
Scanned arrays were analyzed first with Affymetrix GCOS 1.3 software to obtain 
Absent/Present calls and for subsequent analysis with dChip 2006 
(http://www.dchip.org, Wong Lab, Harvard). Four GeneChip chicken arrays used for 
another study were added to the two arrays in this study to ensure a robust model for 
expression value computation: The arrays were normalized to a baseline array with 
median CEL intensity by applying an Invariant Set Normalization Method (Li and 
Wong, 2001). Normalized CEL intensities of the six arrays were used to obtain model-
based gene expression indices based on a PM (Perfect Match)-only model (Kattman et 
al., 2006). Only genes called Present in at least one of the two arrays in this study were 
kept for downstream analysis (17575 genes). All genes compared were considered to be 
differentially expressed if the 90% lower confidence bound of the fold change between 
experiment and baseline was above 2. The lower confidence bound criterion means that 
we can be 90% confident that the fold change is a value between the lower confidence 
bound and a variable upper confidence bound. It has been shown that the lower 
confidence bound is a conservative estimate of the fold change, and therefore more 
reliable as a ranking statistic for changes in gene expression (Li and Wong, 2001). 
4.7. Gene list analysis using bioinformatic resources (DAVID and Ingenuity 
Pathway Analysis) 
Genes identified by Affymetrix and with a fold change calculated greater than 2 were 
used for network and gene ontology analyses.  
Gene accession numbers were uploaded into DAVID (http://david.abcc.ncifcrf.gov/) 
(Huang et al., 2009; Dennis et al., 2003) to filter the redundancy and categorize 
according to the degree of annotation. The set of up and downregulatedgenes was 
subdivided into characterized and uncharacterized. The uncharacterized genes include 
genes that have an ID in Entrez or Ensemble databases (annotated), and genes that do 
not (unknown). The characterized genes are annotated genes that have been published 
(PUBMED ID), some of these with functional information (GeneRIF). 
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Gene accession numbers were imported into the Ingenuity Pathway Analysis version 
8.0 (IPA) software (Ingenuity Systems ®, Mountain View, CA, USA), and are the 
starting point for generating biological networks. IPA then computed a score for each 
network according to the fit of the user’s set of significant genes. A score of 2 indicated 
a 1 in 100 chance that the focus genes were together in a network because of random 
chance. Since the size of the created network could potentially be enormous, the IPA 
software limited the number of molecules in the network to 35, leaving only the most 
important ones based on the number of connections for each focus gene (focus genes = 
a subset of uploaded significant genes having direct interactions with other genes in the 
database) to other significant genes. Networks are scored based on the number of focus 
molecules in the network, its size, the total number of focus molecules analyzed, and the 
total number of molecules in the knowledge database that could potentially be included 
in the networks. 
4.8. Clones selection and whole-mount in situ hybridization 
Chicken EST’s for the selected clones were obtained from the BBSRC chick EST 
database (Hubbard et al., 2004). Clones used were ChEST884h13 for cAdtk1 (seq. 
identifier 603865952F1), ChEST514i19 for CHEP33 (seq. identifier 603542577F1), 
ChEST739g15 for CHEP40 (seq. identifier 603784860F1) and ChEST746d11 for 
CHEP18 (seq. identifier 603787942F1). 
The clones were sequenced using T7 and T3 primers and whole-mount in situ 
hybridization was performed as previously described (Wilknson, 1993). DIG labeled 
RNA probes were generated by digesting plasmids with Not I, and transcribing with T7 
RNA polymerase. 
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Figures 
Figure 1 Expression of Cer2.5-EGFP reporter construct in the chick developing 
embryo. Embryos were targeted at HH3 and electroporated with Cer2.5-EGFP reporter 
construct by microinjection and electroporation in New culture (A,B,C,D,F,G). In panel 
E embryos were electroporated with pCAGGS-AFP (control). A’, D’, F’, G’, and G’’ 
show sections of embryos A, D, F, and G, respectively. In D’, G’ and G’’ cell nuclei are 
labelled with DAPI (blue). 
(A,A’,B,C): EGFP is detected specifically in the lateral anterior mesendoderm. (D,D’): 
EGFP fluorescence is observed specifically in the future extraembryonic mesoderm and 
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heart precursor cells (arrow in D’). (F-G): Expression is localised in the extraembryonic 
mesoderm and cardiogenic region (F,F’), and later in the heart and blood islands (G). In 
G’, fluorescence is seen in the heart (arrow) and in a few cells of the pharynx. In G’’ 
labelled cells are localised both in the endothelium and inside the hematopoietic region 
of the blood islands (arrows). (H): cCer transcripts were detected by whole-mount in 
situ hybridization in the anterior mesendoderm. 
(ames anterior mesendoderm, hf heart fields, mes mesoderm, hp heart precursors, ht 
heart tube, pcar pre cardiac region, endo endothelium, ht heart, pha pharynx, bi blood 
islands) 
 
Figure 2 Strategy for enrichment of transcripts expressed in heart precursor cells. (A): 
Schematic representation of the experimental procedure used for the differential 
screening. The characterized 2.5cCer promoter drives expression of EGFP reporter 
construct in the HPC population (green), but not in other cells (red).  
(B-C): Sorting of GFP positive cells from electroporated embryos. The parameters 
forward scatter (FSC) and green fluorescence intensity (FL1) were used to set sorting 
gates. FACS analysis of dissociated cells in terms of FSC and SSC (B). Cells falling in 
the R8 region were sorted and collected (C). The number of cells at each intensity is 
shown by the number of dots, where each dot represents a single cell. The x-axis, FSC, 
represents the cell size, whereas the y-axis, SSC, represents cytoplasmic granular 
intensity. (D): Semi-quantitative reverse transcriptase-polymerase chain reaction (RT-
PCR) was performed on equivalent amounts of RNA isolated from whole embryo, 
PPPS and the sorted EGFP positive cells at HH4 using primers specific for cNot, 
cNodal, cCer and GAPDH. PCR reactions were terminated after various cycles of 
amplification (20, 25, 30 and 35) and the reaction products were separated by 
electrophoresis and visualized using ethidium bromide. 
 
Figure 3 Analysis of the differentially expressed genes in the HPC. (A): Genes 
identified by Affymetrix with a fold change calculated greater than 2 were uploaded 
into DAVID (http://david.abcc.ncifcrf.gov/) to filter the redundancy and categorize 
according to the degree of annotation. This resulted in the identification of 777 genes 
differentially expressed in the HPC population, which included 437 upregulated and 
340 downregulated. (B): Several of the found upregulated genes have been previously 
associated to heart as well as to hemangioblast precursor cell populations, bars in pink 
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and red respectively. Reference genes, GAPDH and Actin, were found at 1 fold change 
(black bars). The horizontal line indicates the significance threshold.  
Unknown genes don’t have an ID in Entrez or Ensemble databases; Annotated genes 
only have an ID in Entrez or Ensemble databases; PUBMED ID annotated genes that 
have been published; GeneRIF published genes with known functional information. 
 
Figure 4 In vivo validation of the differential screening (cADTK and CHEP33). Whole-
mount in situ hybridization and paraffin sectioning for cADTK (A-H) and CHEP33 (I-
O), in the chick embryo: (A) cADTK expression is seen in the anterior mesendoderm of 
the embryo, including the bilateral heart fields; (B, C and C’) staining can be observed 
in the mesodermal HFRs as well as on either side of the neural folds; (D-E) in early 
somite stages expression is seen in the lateral plate mesoderm and in the proamnion; (F-
H) later in development, staining is visible in the heart (wall of sinus venosus) and 
adjacent endoderm, lateral plate mesoderm and tail bud; (I, J and J’) CHEP33 
expression is present in the prospective HFRs mesoderm; (K) in early somite stage, the 
lateral plate mesoderm and the somites appear stained; (L-N) expression is seen in the 
heart tube, somites; (M-N) head and lateral plate mesoderm; (N’ and N’’) expression 
can be specifically seen in the myocardium, pharyngeal endoderm, neural tube, derma-
myotome and somatic lateral plate mesoderm; (O) Later in development, an intense 
expression is observed in the heart.  
(ames anterior mesendoderm, hf heart fields, np neural plate, nfp neural fold patches, 
mes mesoderm, lpm lateral plate mesoderm, pa pro-amnion, hp heart primordium, ht 
heart, wsv wall of sinus venosus, tbm tail bud mesoderm, s somites, nt neural tube, phe 
pharyngeal endoderm, myo myocardium, dmyo derma-myotome, sm somatic lateral 
plate mesoderm). 
 
Figure 5 In vivo validation of the differential screening (CHEP40 and CHEP18).  
Whole-mount in situ hybridization and paraffin sectioning for CHEP40 (A-F) and 
CHEP18 (G-M), in the chick embryo: (A) CHEP40 is present with greater intensity in 
the anterior part of the area pellucida, except for the primitive streak and Hensen’s 
node, and also in the posterior part of the area opaca; (A’and A’’) the expression is 
visible in the three embryonic layers, endoderm, mesoderm and ectoderm; (B) staining 
is observed heavily in the entire area pellucida except for the primitive streak, Hensen’s 
node and head process; (C) at early somite stage CHEP40 expression is seen in the heart 
	   28	  
primordium; (D-F and D’-E’’) after heart tube formation expression is seen in the heart 
endocardium (D’, E’ and E’’), intraembryonic vasculature (D-F and E’), endoderm 
adjacent to the sinu-atrial region (D’) and neural fold tip (D’ and E’); (G) CHEP18 
expression is present in the posterior and lateral part of the area opaca; (H-K and H’-
J’’) staining can be observed in the mesodermal layer on either side of Hensen’s node 
(black arrowhead); (J-L and J’’, K’-L’’) intraembryonic and extraembryonic vasculature 
appear stained; (L and M) expression is seen between the somites (white arrowheads); 
(M) in the posterior cardinal veins and in the head microvessels; (L, L’, M and M’) and 
in the heart. 
(PS Primitive Streak; ec ectoderm; mes mesoderm; en endoderm; HN Hensen´s node 
HP head process; hp heart primordium; ht heart; iev intraembryonic vasculature; nf 
neural fold; He Heart endocardium; eem extraembryonic mesoderm; eev 
extraembryonic vasculature; hm head mesenchyme; sm somatic lateral plate mesoderm; 
sp splanchnic lateral plate mesoderm; mv microvessels; pCV posterior cardinal veins;) 
 
Tables 
Table 1. Upregulated Top Network Associated Functions 
ID Molecules in Network Score Focus 
Molecules 
Top Functions 
1 Cadherin, CADM1*, CDH5, CDH11, 
CDH20, CHEK2, COL1A2*, Collagen 
type I, FHL2, FIGF, FLT1*, GAD1, 
Gata, HHEX, ISL1, ITGB1BP1, KDR*, 
LIPG, LMO2, MPP3, NFkB (complex), 
NRP1, PBX3, PCSK5*, PLC gamma, 
PLK2, PLXNA4*, PTN, RBM16, RNA 
polymerase II, TAF1D*, TAL1, TLL1, 
Vegf, Vegf Receptor 
45 27 Cellular 
Movement, 
Cardiovascular 
System 
Development 
and Function, 
Cellular 
Development 
Genes in boldface were identified by microarray analysis to be expressed differentially 
more than 2 fold (Focus Genes). Other genes were either not on the expression array or 
not significantly regulated. (*) duplicated gene in the data set. 
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